IMV Inc (IMVIF)
0.0002
0.00 (0.00%)
USD |
OTCM |
Jul 02, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 0.0023M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -99.75% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | -- |
| Price to Book Value | -- |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -- |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 100.0% |
Profile
| IMV Inc is a clinical-stage biopharmaceutical company. The company is engaged in making immunotherapies more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. Its proprietary drug development platform provides a patented delivery formulation that enables controlled and prolonged exposure of antigens to the immune system. |
| URL | https://www.imv-inc.com |
| Investor Relations URL | https://www.imvaccine.com/investors.php |
| HQ State/Province | Nova Scotia |
| Sector | |
| Industry | |
| Equity Style | Small Cap/Value |
| Next Earnings Release | Jul. 11, 2024 (est.) |
| Last Earnings Release | Mar. 16, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| IMV Inc is a clinical-stage biopharmaceutical company. The company is engaged in making immunotherapies more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. Its proprietary drug development platform provides a patented delivery formulation that enables controlled and prolonged exposure of antigens to the immune system. |
| URL | https://www.imv-inc.com |
| Investor Relations URL | https://www.imvaccine.com/investors.php |
| HQ State/Province | Nova Scotia |
| Sector | |
| Industry | |
| Equity Style | Small Cap/Value |
| Next Earnings Release | Jul. 11, 2024 (est.) |
| Last Earnings Release | Mar. 16, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |